# The Effects of a Sublingual Sprayable Microemulsion of Vitamin D on Inflammatory Markers in COVID-19 Patients

> **NCT05502068** · NA · COMPLETED · sponsor: **Pauls Stradins Clinical University Hospital** · enrollment: 102 (actual)

## Conditions studied

- COVID-19
- Vitamin D Deficiency

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion

## Key facts

- **NCT ID:** NCT05502068
- **Lead sponsor:** Pauls Stradins Clinical University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-06-09
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2022-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05502068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05502068, "The Effects of a Sublingual Sprayable Microemulsion of Vitamin D on Inflammatory Markers in COVID-19 Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05502068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
